INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune drug targets liver tumors in advanced cancer trial
Disease control Recruiting nowThis study is testing whether adding a new immune-stimulating drug called PDS01ADC to a specialized liver cancer treatment can better control advanced cancers that have spread to the liver. The treatment involves surgically placing a pump that delivers chemotherapy directly to th…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for tough liver cancer: Triple-Threat therapy tested
Disease control Recruiting nowThis study is testing a new combination of three drugs as the first treatment for advanced bile duct cancer that cannot be removed by surgery. The goal is to see if adding two newer drugs (apatinib and adebrelimab) to standard chemotherapy can shrink tumors better and help patien…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for tough liver cancer: triple attack trial
Disease control Recruiting nowThis study is testing whether a three-part treatment can better control advanced bile duct cancer that starts in the liver. Researchers will give chemotherapy directly to the liver through an artery, combined with two drugs that work throughout the body. The trial aims to see if …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New blood test aims to spot deadly bile duct cancer earlier
Diagnosis Recruiting nowThis study is testing a new blood test designed to improve the detection and management of bile duct cancers, which are often diagnosed late and have poor survival rates. The test looks for specific chemical markers released by cancer cells into the bloodstream. Researchers will …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Sponsor: Yingbin Liu, MD, PhD, FACS • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
New scan could spot hidden cancer better
Diagnosis Recruiting nowThis study is testing a new type of imaging scan to see if it can better detect and track bile duct and gallbladder cancers. Researchers will compare the new FAPI PET scan to the standard FDG PET scan in 60 adult patients. The goal is to see if the new scan provides clearer pictu…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Sponsor: Tata Memorial Centre • Aim: Diagnosis
Last updated Mar 30, 2026 14:32 UTC
-
New 'Cancer-Hunting' scan seeks to pinpoint Hard-to-Find tumors
Diagnosis Recruiting nowThis study is testing a new imaging agent called 89Zr-TLX250 to see if it can help doctors better detect and locate three specific types of cancer using a PET-CT scan. The trial will involve 60 adults with liver cancer, bile duct cancer, or certain neuroendocrine tumors. The main…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: NA • Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated Mar 25, 2026 14:08 UTC